Report of the 18th follow-up survey of primary liver cancer in Japan

Hepatology Research

Volumn 40, Issue 11, 2010, Pages 1043-1059

  Ikai, Iwao ^a   Kudo, Masatoshi ^a   Arii, Shigeki ^a   Omata, Masao ^a   Kojiro, Masamichi ^a   Sakamoto, Michiie ^a   Takayasu, Kenichi ^a   Hayashi, Norio ^a   Makuuchi, Masatoshi ^a   Matsuyama, Yutaka ^a   Monden, Morito ^a  

^a The Liver Cancer Study Group of Japan   (Japan)

Author keywords

Combined hepatic carcinoma; Cumulative survival rate; Follow up survey; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS ANTIBODY;

ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HEPATOBLASTOMA; HISTOLOGY; HUMAN; JAPAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UNDIFFERENTIATED CARCINOMA;

EID: 77958583600     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00731.x     Document Type: Article

References (19)

1. Okuda K, The Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980; 45: 2663-9.
2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1984; 54: 1747-55.
3. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan-Sixth report. Cancer 1987; 60: 1400-11.
4. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990; 211: 277-87.
5. Primary Liver Cancer in Japan. Tobe T et al. Springer-Verlag Tokyo, Berlin, Heidelberg, New York, London, Paris, Hong Kong, Barcelona 1992.
6. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
7. Arii S, Yamaoka Y, Futagawa S et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The liver cancer study group of Japan. Hepatology 2000; 32: 1224-9.
8. Ikai I, Itai Y, Okita K et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 2004; 28: 21-9.
9. Ikai I, Arii S, Kojiro M et al. Re-evaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004; 101: 796-802.
10. Ikai I, Arii S, Ichida T et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 2005; 32: 163-72.
11. Ikai I, Arii S, Okazaki M et al. Report of the 17th nationwide follow-up survey of primary liver cancer. in Japan. Hepatol Res 2007; 37: 676-91.
12. Takayasu K, Arii S, Ikai I et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-9.
13. Ikai I, Takayasu K, Omata M et al. A modified Japan integrated stage score for prognostic assessment in patients with hepatocellular carcinoma. J Gastroenterol 2006; 41: 884-92.
14. Minagawa M, Ikai I, Matsuyama Y et al. Staging of Hepatocellular Carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13 772 patients in Japan. Ann Surg 2007; 245: 909-22.
15. Eguchi S, Kanematsu T, Arii S et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-75.
16. Hasegawa K, Makuuchi M, Takayama T et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49: 589-94.
17. Takayasu K, Arii S, Ikai I et al. Liver Cancer Study Group of Japan. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol 2010; 194: 830-7.
18. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Second English Edition. Tokyo: Kanehara & Co., Ltd., 2003.
19. Kudo M, Kubo S, Takayasu K et al. Response evaluation criteria in cancer of the liver (RECICL) proposed by the liver cancer study group of Japan (2009 revised version). Hepatol Res 2010; 40: 686-62.